
Korean drugmakers scramble for clarity as US weighs drug tariffs amid price-cut push
Korea’s pharmaceutical and biotech industry is grappling with growing uncertainty as the U.S. government shifts its trade and healthcare policy landscape—raising the specter of import tariffs on medicines just as it pushes to lower prescription drug prices …